Why Cochlear Ltd shares are the best present for the kids this Xmas

Whatever the time of year, some shares like Cochlear Ltd (ASX:COH) will always be among the best to own for smart investors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This is the time of year when many talking heads, analysts and share market commentators like to predict what will be the best-performing stocks or sectors in the year ahead.

And I'm not kidding when I say that in my role as the editor for The Motley Fool Australia that I get to hear a lot about the latest hot companies either recommended by readers, shareholders, or the companies themselves.

In all honesty most of them are rubbish. These are the kind of companies losing money, with no products, no track record, opaque management and almost no chance of ever producing strong long-term returns for investors.

In fact there are hundreds of companies all over the ASX that don't make money, have too much debt, no competitive advantages and virtually zero potential to consistently grow profits over the long term.

Still you'd be surprised just how many Australians love to buy shares in these types of companies out of general ignorance, or in the hope of getting rich quick.

If you're looking to invest for your kids or grandchildren this Christmas, I suggest you avoid almost the entire market.

As you'll need to find a company with a proven market-leading product that's built for the future.

I suggest investors look to hearing aid manufacturer Cochlear Limited (ASX: COH). Not only does it have market-leading products, but it also has an almost unlimited addressable global market and infinite growth runway.

The fact that its hearing aids are best-in-class means it can command premium prices as patients will always want the best products possible when it comes to their hearing. These are not the kind of products or commodities (like baby formula) that can go boom or bust depending on whether a competitor simply replicates them, or as supply and demand swings over cycles.

Moreover, after a recent share price pull back based largely around valuation and a wobble for growth stocks due to the changing outlook for the risk-free rate of returns, Cochlear shares are now trading at a reasonable valuation under $120.

Anyone betting against Cochlear shares?

screen-shot-2016-12-22-at-4-20-30-pm

Chart: Cochlear share price performance since April 1999, up 1,000%.

For comparison are Commonwealth Bank of Australia (ASX: CBA) shares up 214% and Telstra Corporation Ltd (ASX: TLS) shares down 40% over the same period.

Not forgetting the king of widely-held dud stocks in AMP Limited (ASX: AMP), down 71% over the period.

Of course Cochlear like other healthcare leaders including CSL Limited (ASX: CSL) is not without risks, as it has been forced to recall products in the past and is vulnerable to mismanagement or cut-price competition of sorts.

Still, to me there's probably not a better long-term growth stock on the ASX and I expect it would make an ideal present for parents looking to invest for their children's future this Christmas.

Motley Fool contributor Tom Richardson owns shares of Cochlear Ltd. and CSL Ltd. You can find Tom on Twitter @tommyr345 The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »